M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Acelrx Pharmaceuticals Inc to acquire Lowell Therapeutics
Announced Nov 15, 2021 · Closed Jan 12, 2022 · Private target
Deal value$33M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationCash and stock
Transaction
- Acquirer
- Acelrx Pharmaceuticals Inc (ACRX)
- Target
- Lowell Therapeutics
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Jan 12, 2022
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations